natgillin/translations-raw huggingface dataset:
HU 1/2003 ‘Earmarked Scheme for Investment Promotion’ was submitted under the interim procedure and accepted by the Commission as existing aid within the meaning of Annex IV, Chapter 3, paragraph (1)(c) (under Article 22) of the Treaty of Accession of the Czech Republic, Estonia, Cyprus, Latvia, Lithuania, Hungary Malta, Poland, Slovenia and Slovakia to the European Union.
HU 1/2003 „Namenski program za spodbujanje naložb“ je bil predložen po začasnem postopku in Komisija ga je odobrila kot obstoječo pomoč v smislu odstavka (1)(c) poglavja 3 Priloge IV (v skladu s členom 22) Pogodbe o pristopu Češke, Estonije, Cipra, Latvije, Litve, Madžarske, Malte, Poljske, Slovenije in Slovaške k Evropski uniji.
HU 3/2004 ‘Development Tax Benefit Scheme’ was submitted under the interim procedure and accepted by the Commission as existing aid within the meaning of Annex IV, Chapter 3, paragraph (1)(c) (under Article 22) of the Treaty of Accession of the Czech Republic, Estonia, Cyprus, Latvia, Lithuania, Hungary Malta, Poland, Slovenia and Slovakia to the European Union.
HU 3/2004 „Program davčnih ugodnosti za razvoj“ je bil predložen po začasnem postopku, in Komisija ga je odobrila kot obstoječo pomoč v smislu odstavka (1)(c) poglavja 3 Priloge IV (na podlagi člena 22) Pogodbe o pristopu Češke, Estonije, Cipra, Latvije, Litve, Madžarske, Malte, Poljske, Slovenije in Slovaške k Evropski uniji.
The amendment of the scheme was notified to the Commission (case number N 504/2004) and approved by the Commission on 23 December 2004 (ref. C(2004) 5652).
Sprememba programa je bila priglašena Komisiji (številka zadeve N 504/2004) in jo je Komisija odobrila 23. decembra 2004 (sklic C(2004) 5652).
In this decision, the net grant equivalent (NGE) is calculated on the basis of the standard corporate tax rate applicable in Hungary (16 %).
V tej odločbi je neto ekvivalent dotacije (NED) izračunan na podlagi standardne stopnje davka na pravne osebe, veljavne na Madžarskem (16 %).
The tax allowance is capped in terms of its overall present value.
Davčna olajšava je omejena glede svoje skupne sedanje vrednosti.
HU 1/2003 ‘Earmarked Scheme for Investment Promotion’ and N 504/2004 (ex HU 3/2004) ‘Development Tax Benefit Scheme’.
HU 1/2003 „Namenski program za spodbujanje naložb“ in N 504/2004 (ex HU 3/2004) „Program davčnih ugodnosti za razvoj“.
Differences in the intended use between the end products, DPF and DOC, are a reflection of the different uses of their respective substrates.
Razlike v predvideni uporabi med končnima proizvodoma, DPF in DOC, so odraz različnih uporab posameznih substratov.
Therefore, hereafter in the decision DPF will be used alternatively to substrate of DPF.
Zato bosta v nadaljevanju odločbe uporabljena tako izraz substrat DPF kot izraz DPF.
‘Strategic analysis of the European market for Diesel Particulate Filters’, October 2006.
„Strateška analiza evropskega trga za filtre za trdne delce za dizelske motorje“, oktober 2006.
The firm Frost & Sullivan is active in market/industry consulting and research.
Podjetje Frost & Sullivan je dejavno na področju tržnega/industrijskega svetovanja in raziskav.
‘Market survey on PM reduction after-treatment devices’, March 2007.
„Tržna raziskava o napravah za redukcijsko naknadno obdelavo delcev“, marec 2007.
AVL List is closely involved with the design and development of internal combustion engines.
Podjetje AVL List je tesno povezano z oblikovanjem in razvojem motorjev z notranjim izgorevanjem.
The AVL study, which was commissioned by IBIDEN HU for the present case, argues that both DOC and DPF belong to the same relevant product market, however, the data and analysis presented in the AVL study do not confirm this argument, i.e. various elements/information in the study indicate the absence of substitutability, and not the opposite.
Raziskava AVL, ki jo je naročila družba IBIDEN HU za to zadevo, trdi, da tako DOC kot DPF spadata v isti upoštevni proizvodni trg, vendar pa podatki in analiza, predstavljeni v raziskavi AVL ne potrjujejo te trditve, tj. različni elementi/informacije v raziskavi kažejo na odsotnost zamenljivosti in ne nasprotno.
The concept of subsequent generations of the product is used by IBIDEN HU to refer to the evolution of the technology.
Družba IBIDEN HU uporablja koncept zaporednih generacij proizvoda za sklicevanje na razvoj tehnologije.
However, as regards the DOC's market price of EUR 102, as provided in the AVL study, it seems that it refers to the DOC price after coating at TIER 2 as well, and therefore the price of the DOC substrate would need to be adjusted downwards the same way as IBIDEN adjusted DPF's substrate prices.
Toda kar zadeva tržno ceno DOC v višini 102 EUR, kot je podana v raziskavi AVL, se zdi, da se nanaša tudi na ceno DOC po nanašanju prevleke na STOPNJI 2, zato bi bilo treba ceno substrata za DOC prilagoditi navzdol, tako kot je IBIDEN prilagodil cene substrata za DPF.
Because investment projects may continue over several years, the three year period is calculated, in principle, from the start of works on each project.
Ker lahko naložbeni projekti trajajo več let, se triletno obdobje načeloma računa od začetka del na posameznem projektu.
DPF is not yet required by the current European legislation, but is already installed in certain motor vehicles.
DPF še ni obvezen v skladu z veljavno evropsko zakonodajo, je pa že vgrajen v nekatera motorna vozila.
From September 2009 onwards, new limit values will become mandatory for new types of diesel passenger cars (category M1) and light duty commercial vehicles (category N1 class I) with a reference mass not exceeding 2610 kg (these limits will apply for classes II and III of N1 and N2 vehicles as from September 2010).
Od septembra 2009 bodo za nove vrste osebnih avtomobilov z dizelskim motorjem (kategorija M1) in lahkih gospodarskih vozil (razred I kategorije N1), katerih referenčna masa ne presega 2610 kg (te omejitve bodo veljale za razred II in III vozil kategorije N1 in N2 od septembra 2010), postale obvezne nove mejne vrednosti.
This will in practice result in the instalment of DPFs in order to fulfil the limit values.
To bo v praksi privedlo do vgrajevanja DPF z namenom izpolnjevanja mejnih vrednosti.
The Hungarian authorities confirmed that IBIDEN Deutschland GmbH is a trade and marketing company, and it does not produce exhaust gas treatment parts.
Madžarski organi so potrdili, da je IBIDEN Deutschland GmbH družba za prodajo in trženje in ne proizvaja delov za obdelavo izpušnih plinov.
No other IBIDEN Group's company carries out any further processing on the parts produced by IBIDEN HU.
Nobena druga družba skupine IBIDEN Group ne izvaja nikakršne nadaljnje obdelave na delih, ki jih proizvaja IBIDEN HU.
SOF: soluble organic fraction like organic material derived from engine lubricating oil and from fuel.
Topna organska frakcija, kot je organska snov, pridobljena iz olja za mazanje motorja in iz goriva.
Regulation (EC) No 715/2007 of the European Parliament and of the Council of 20 June 2007 on type approval of motor vehicles with respect to emissions from light passenger and commercial vehicles (Euro 5 and Euro 6) and on access to vehicle repair and maintenance information (OJ L 171, 29.6.2007, p. 1).
Uredba (ES) št. 715/2007 Evropskega parlamenta in Sveta z dne 20. junija 2007 o homologaciji motornih vozil glede na emisije iz lahkih potniških in gospodarskih vozil (Euro 5 in Euro 6) ter o dostopu do informacij o popravilu in vzdrževanju vozil (UL L 171, 29.6.2007, str. 1).
This trend, as illustrated by Saint-Gobain, is underlined by the various presentations given during various expert forums in 2007 by General Motors, DaimlerChrysler, Johnson Matthey, Hyundai and Arvin Meritor.
Ta trend, kot ponazarja Saint-Gobain, podkrepljujejo različne predstavitve z različnih strokovnih forumov družb General Motors, DaimlerChrysler, Johnson Matthey, Hyundai in Arvin Meritor v letu 2007.
According to the market study by AVL, modern exhaust after-treatment systems need sulphur free diesel fuel to ensure effective and durable performance.
Glede na tržno raziskavo družbe AVL je za sodobne sisteme za naknadno obdelavo izpušnih plinov potrebno dizelsko gorivo brez žvepla, da se tako zagotovi učinkovito in trajno delovanje.
Low sulphur diesel fuel was introduced in the EU in 2005 and will be mandatory in 2009.
Dizelsko gorivo z nizko vsebnostjo žvepla je bilo v EU uvedeno leta 2005, leta 2009 pa bo postalo obvezno.
Data compiled by AVL reflect a somewhat smaller market than F&S and would result in inconsistencies as the volume of the beneficiary's sales in Europe before the investment (i.e. in 2003) is higher then total sales estimated by AVL.
Podatki, ki jih je zbrala družba AVL, odražajo nekoliko manjši trg kakor tisti podjetja F&S in bi povzročili neskladja, saj je obseg prodaje upravičenca v Evropi pred naložbo (tj. v letu 2003) višji od celotne prodaje, kot jo je ocenila družba AVL.
Therefore for the DPF market figures contained in the F&S study were used where no such inconsistencies arose.
Zato so bili uporabljene številke za trg DPF iz raziskave družbe F&S, v kateri se taka neskladja niso pojavila.
Moreover, taking the higher F&S data is in favour of the beneficiary, but even in this scenario, market shares are well above 25 %.
Poleg tega so višje vrednosti podjetja F&S v prid upravičencu, vendar so tudi po tem scenariju tržni deleži precej nad 25 %.
The F&S study directly refers to the number of DPFs sold or expected to be sold on the market taking into account all manufacturers of DPFs.
Raziskava podjetja F&S se nanaša neposredno na število DPF, ki so bodisi prodani ali pa naj bi bili prodani na trgu, upoštevajoč vse proizvajalce DPF.
It should also be noted that although the studies refer to DPF, i.e. the ready-made downstream product, in practice the volume of substrates sold equals the number of DPFs sold.
Opozoriti je treba tudi, da čeprav se raziskave nanašajo na DPF, tj. gotov proizvod v poproizvodni fazi, je v praksi količina prodanih substratov enaka številu prodanih DPF.
IBIDEN HU's ceramic substrate is an intermediary product which is subject to further processing (i.e. coating, canning) at subsequent levels of the value chain (carried out by independent companies).
Keramični substrat družbe IBIDEN HU je vmesni proizvod, ki je predmet nadaljnje obdelave (tj. prevlečenja, konzerviranja) na kasnejših ravneh vrednostne verige (ki jo izvajajo neodvisne družbe).
Since data in value terms contained in the submitted studies refer only to the ready made DPF whose price is substantially higher that that of IBIDEN's product, and since no reliable data has been submitted as regards the price of the intermediary product, the Commission considers that in the case at hand, analysis in volume terms should be used.
Ker se v vrednosti izraženi podatki, ki jih vsebujejo predložene raziskave, nanašajo le na gotovi DPF, katerega cena je bistveno višja kot cena proizvoda družbe IBIDEN, in ker ni bilo predloženih zanesljivih podatkov o ceni vmesnega proizvoda, Komisija meni, da bi bilo treba v tej zadevi uporabiti analizo, ki se nanaša na podatke, izražene v količini.
In any event, if IBIDEN sells DPF substrates at close to the average market price, market shares in value terms would be comparable.
V vsakem primeru bi bili v vrednosti izraženi tržni deleži primerljivi, če IBIDEN proda substrate za DPF po ceni, podobni povprečni tržni ceni.
According to data provided by Saint-Gobain, even in a hypothetical market comprising substrates for both DPF and DOC (DPF + DOC market), IBIDEN's market share is above 25 % in value terms in the EEA.
Po podatkih, ki jih je posredovala družba Saint-Gobain, je celo na hipotetičnem trgu, ki zajema substrate za DPF in za DOC (trg DPF + DOC), v vrednosti izražen tržni delež družbe IBIDEN v EGP višji od 25 %.
However, this argument is not confirmed by the AVL study (which was commissioned by the beneficiary), as it indicates substantially higher prices of DOCs and thus a market share in value terms remains below 25 % in the combined market (however, as regards the market price of the DOC as provided in the AVL study, it would seem that this refers to the DOC price after coating at TIER 2, which would explain the significantly higher price compared with the one indicated for the substrate by Saint-Gobain).
Vendar pa raziskava družbe AVL (ki jo je naročil upravičenec) tega argumenta ne potrjuje, saj navaja bistveno višje cene DOC, tako da v vrednosti izražen tržni delež na združenem trgu ostaja pod 25 % (kar pa zadeva tržno ceno DOC iz raziskave družbe AVL, se zdi, da se nanaša na ceno DOC po prevlečenju na STOPNJI 2, kar bi pojasnilo bistveno višjo ceno v primerjavi s tisto, ki jo za substrat navaja družba Saint-Gobain).
Therefore, on the basis of the available information it cannot be concluded whether in such a hypothetical market IBIDEN's market share would be above or below 25 % in value terms in the EEA.
Zato na osnovi razpoložljivih informacij ni mogoče ugotoviti, ali bi bil na takem hipotetičnem trgu v vrednosti izražen tržni delež družbe IBIDEN v EGP višji ali nižji od 25 %.
For practical reasons, EU-27 GDP figures were considered.
Iz praktičnih razlogov so bili upoštevani podatki o BDP v EU-27.
CAGR: Compound annual growth rate.
SLSR: sestavljena letna stopnja rasti
The aid beneficiary is ‘IBIDEN Hungary Gyártó Kft.’ (hereinafter: IBIDEN HU).
Upravičenec do pomoči je „IBIDEN Hungary Gyártó Kft.“ (v nadaljnjem besedilu: IBIDEN HU).
Moreover, the substrate for DOC is a single block honeycomb cylinder whereas the DPF substrate is formed by gluing several filtering elements and the channels of the DPF are plugged, which is not the case for DOC. It follows then that the production of the DPF substrate necessitates a non oxide high temperature sintering furnace, gluing system and plugging machines and these equipments are not necessary for the production of the DOC substrate. It appears therefore that it is not possible to produce DPF and DOC substrate on the same production lines without significant additional costs.
Poleg tega je substrat za DOC satasti valj v enem bloku, medtem ko je substrat za DPF oblikovan z lepljenjem več filtrirnih elementov, kanali DPF pa so zamašeni, kar pa ne drži za DOC. Iz tega sledi, da so za proizvodnjo substrata za DPF potrebni neoksidna visokotemperaturna peč za sintranje, sistem za lepljenje in mašilne naprave, ki pa niso potrebni za proizvodnjo substrata za DOC. Kaže torej, da substrata za DPF in za DOC ni mogoče proizvajati na istih proizvodnih linijah brez znatnih dodatnih stroškov.
CAGR [35]
SLSR [35]
of 31 October 2008
z dne 31. oktobra 2008
setting a new deadline for the submission of dossiers for certain substances to be examined under the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC
o določitvi novega roka za predložitev dosjejev za nekatere snovi, ki jih je treba preučiti v okviru 10-letnega programa dela iz člena 16(2) Direktive 98/8/ES
(notified under document number C(2008) 6266)
(notificirano pod dokumentarno številko C(2008) 6266)
For a number of substances/product-type combinations included in that list, either all participants have withdrawn or no dossier has been received within the deadline specified in Article 9(2)(c) of Regulation (EC) No 1451/2007 by the Member State designated as rapporteur for the evaluation.
Za mnoge kombinacije snovi/vrst pripravkov, vključene v navedeni seznam, so se bodisi vsi udeleženci umaknili bodisi države članice, imenovane za poročevalke pri ocenjevanju, niso prejele dosjejev do roka iz člena 9(2)(c) Uredbe (ES) št. 1451/2007.
Within three months of the electronic publication of that information, companies indicated an interest in taking over the role of participant for some of the substances and product-types concerned, in accordance with Article 12(1) of Regulation (EC) No 1451/2007.
V treh mesecih po elektronski objavi navedenega obvestila so družbe izrazile zanimanje, da bi prevzele vlogo udeležencev za nekatere zadevne snovi in vrste pripravkov v skladu s členom 12(1) Uredbe (ES) št. 1451/2007.
A new deadline should therefore be established for the submission of dossiers for these substances and product-types in accordance with the second subparagraph of Article 12(3) of that Regulation.
Zato je treba v skladu z drugim pododstavkom člena 12(3) navedene uredbe določiti novi rok za predložitev dosjejev za te snovi in vrste pripravkov.
For the substances and the product-types set out in the Annex, the new deadline for the submission of dossiers shall be 1 December 2009.
Za snovi in vrste pripravkov iz Priloge je novi rok za predložitev dosjejev 1. december 2009.
Done at Brussels, 31 October 2008.
V Bruslju, 31. oktobra 2008
Substances and product-types for which the new deadline for the submission of dossiers is 1 December 2009
Snovi in vrste pripravkov, za katere je novi rok za predložitev dosjejev 1. december 2009
Producttype
Vrsta pripravkov
Hexa-2,4-dienoic acid/Sorbic acid
heksa-2,4-dienojska kislina/sorbinska kislina
Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol
zmes cis- in trans-p-mentan-3,8 diola/citriodiol
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)
oligo(2-(2-etoksi)etoksietilgvanidinijev klorid)
Poly(hexamethylendiamine guanidinium chloride)
poli(heksametilendiamin gvanidijev klorid)
Potassium (E,E)-hexa-2,4-dienoate
kalijev (E,E)-heksa-2,4-dienoat
Pyridine-2-thiol 1-oxide, sodium salt
piridin-2-tiol 1-oksid, natrijeva sol
Salicylic acid
salicilna kislina
Silicon dioxide — amorphous
silicijev dioksid – amorfni
Triclosan
triklozan
Polymer of formaldehyde and acrolein
polimer formaldehida in akroleina
of 3 November 2008
z dne 3. novembra 2008
concerning the non-inclusion of bromuconazole in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance
o nevključitvi bromukonazola v Prilogo I k Direktivi Sveta 91/414/EGS in o preklicu registracij fitofarmacevtskih sredstev, ki vsebujejo navedeno snov
(notified under document number C(2008) 6290)
(notificirano pod dokumentarno številko C(2008) 6290)
Article 8(2) of Directive 91/414/EEC provides that a Member State may, during a period of 12 years following the notification of that Directive, authorise the placing on the market of plant protection products containing active substances not listed in Annex I to that Directive that are already on the market two years after the date of notification, while those substances are gradually being examined within the framework of a programme of work.
Člen 8(2) Direktive 91/414/EGS določa, da lahko država članica v obdobju dvanajstih let po notifikaciji navedene direktive registrira za dajanje v promet fitofarmacevtska sredstva z aktivnimi snovmi, ki niso uvrščene v Prilogo I k navedeni direktivi in so v prometu že dve leti po datumu notifikacije, medtem ko se navedene snovi postopno preučujejo v okviru delovnega programa.
That list includes bromuconazole.
Navedeni seznam vključuje bromukonazol.
For bromuconazole the effects on human health and the environment have been assessed in accordance with the provisions laid down in Regulations (EC) No 451/2000 and (EC) No 1490/2002 for a range of uses proposed by the notifier.
Vplivi bromukonazola na zdravje ljudi in okolje so bili ocenjeni v skladu z določbami uredb (ES) št. 451/2000 in (ES) št. 1490/2002 za vrsto uporab, ki jih je predlagal prijavitelj.
For bromuconazole the rapporteur Member State was Belgium and all relevant information was submitted on 14 November 2005.
Država članica poročevalka za bromukonazol je bila Belgija, vse ustrezne informacije pa so bile predložene 14. novembra 2005.
The assessment report has been peer reviewed by the Member States and the EFSA within its Working Group Evaluation and presented to the Commission on 26 March 2008 in the format of the EFSA conclusion regarding the peer review of the pesticide risk assessment of the active substance bromuconazole [4].
Poročilo o oceni so v okviru delovne skupine za ocenjevanje pregledali strokovnjaki držav članic in EFSA ter ga 26. marca 2008 predložili Komisiji v obliki sklepa EFSA o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo bromukonazol [4].
This report has been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 11 July 2008 in the format of the Commission review report for bromuconazole.
To poročilo so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 11. julija 2008 v obliki poročila Komisije o pregledu glede bromukonazola.
In particular, based on the available information, it was not possible to assess the potential contamination of surface water and groundwater.
Na podlagi razpoložljivih informacij zlasti ni bilo mogoče izvesti zanesljive ocene morebitnega onesnaženja površinske vode in podtalnice.
Moreover, with regard to ecotoxicology, there are concerns due to the high risk to aquatic organisms.
Poleg tega se pojavljajo še pomisleki v zvezi z ekotoksikologijo zaradi visokega tveganja pri vodnih organizmih.
Consequently, it was not possible to conclude on the basis of the information available that bromuconazole met the criteria for inclusion in Annex I to Directive 91/414/EEC.
Zato na podlagi razpoložljivih informacij ni bilo mogoče skleniti, da bromukonazol izpolnjuje pogoje za vključitev v Prilogo I k Direktivi 91/414/EGS.
However, despite the arguments put forward by the notifier, the concerns identified could not be eliminated, and assessments made on the basis of the information submitted and evaluated during the EFSA expert meetings have not demonstrated that it may be expected that, under the proposed conditions of use, plant protection products containing bromuconazole satisfy in general the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC.
Toda kljub argumentom, ki jih je prijavitelj predložil, se navedenih pomislekov ni dalo odpraviti, po ocenah na podlagi predloženih informacij, preučenih na srečanjih strokovnjakov EFSA, pa ne kaže pričakovati, da bi lahko fitofarmacevtska sredstva, ki vsebujejo bromukonazol, pod predvidenimi pogoji uporabe na splošno izpolnjevala zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS.
Bromuconazole should therefore not be included in Annex I to Directive 91/414/EEC.
Bromukonazol se zato ne sme vključiti v Prilogo I k Direktivi 91/414/EGS.
Measures should be taken to ensure that authorisations granted for plant protection products containing bromuconazole are withdrawn within a fixed period of time and are not renewed and that no new authorisations for such products are granted.
Sprejeti je treba ukrepe za zagotovitev, da se registracije fitofarmacevtskih sredstev, ki vsebujejo bromukonazol, prekličejo v predpisanem roku in se ne podaljšajo ali izdajo nove registracije takih sredstev.
Any period of grace granted by a Member State for the disposal, storage, placing on the market and use of existing stocks of plant protection products containing bromuconazole should be limited to twelve months in order to allow existing stocks to be used in one further growing season, which ensures that plant protection products containing bromuconazole remain available to farmers for 18 months from the adoption of this Decision.
Če države članice odobrijo podaljšanje roka za odstranjevanje, skladiščenje, dajanje v promet in uporabo obstoječih zalog fitofarmacevtskih sredstev, ki vsebujejo bromukonazol, ga je treba omejiti na obdobje dvanajstih mesecev, da se omogoči uporaba obstoječih zalog v naslednji rastni sezoni, tako da bodo fitofarmacevtska sredstva, ki vsebujejo bromukonazol, kmetom na voljo še 18 mesecev po sprejetju te odločbe.
This Decision does not prejudice the submission of an application for bromuconazole according to the provisions of Article 6(2) of Directive 91/414/EEC, the detailed implementation rules of which have been laid down in Commission Regulation (EC) No 33/2008 [5], in view of a possible inclusion in its Annex I.
Ta odločba ne vpliva na predložitev zahtevka za bromukonazol v skladu z določbami člena 6(2) Direktive 91/414/EGS, katere podrobna izvedbena pravila so določena v Uredbi Komisije (ES) št. 33/2008 [5], zaradi morebitne vključitve v Prilogo I k navedeni direktivi.